Form 4: Precision BioSciences Executive Sells Shares to Cover Taxes After RSU Vesting
SEC Form 4 Filing
J. Jefferson Smith, Chief Research Officer at Precision BioSciences, sold shares to cover tax obligations following the vesting of restricted stock units.
Summary
- J. Jefferson Smith, the Chief Research Officer of Precision BioSciences, engaged in transactions involving the company's stock.
- On January 20, 2025, Smith's restricted stock units (RSUs) partially vested, resulting in the acquisition of 29,168 shares.
- Following the vesting, Smith sold 10,287 shares on January 22, 2025, at a price of $4.79 per share.
- These sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on April 25, 2024.
- The shares were sold solely to cover tax withholding obligations related to the vesting of the RSUs.
- Smith also holds 7,931 shares indirectly through a Charitable Remainder Unitrust.
- The vesting of RSUs on January 20, 2025, included 2,500 RSUs granted on January 20, 2023, 10,449 RSUs granted on April 18, 2024, and 16,219 RSUs granted on August 22, 2024.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction related to executive compensation and tax obligations. It is not indicative of any positive or negative sentiment towards the company's performance.
Industry Context
This is a routine transaction for executives who receive stock-based compensation. The use of a 10b5-1 plan is common to avoid accusations of insider trading.
Comparison to Industry Standards
- The use of Rule 10b5-1 trading plans is a standard practice among publicly traded companies to allow insiders to sell shares without violating insider trading laws.
- Many biotech companies use RSUs as part of their compensation packages, and it is common for executives to sell shares to cover taxes upon vesting.
- Comparable companies such as CRISPR Therapeutics and Editas Medicine also see similar transactions from their executives.
Stakeholder Impact
- The stock sale by an executive may have a minor impact on the share price, but it is not expected to be significant given the pre-planned nature of the transaction.
Key Dates
| Date | Description |
|---|---|
| 01/20/2023 | Date of grant for some of the Restricted Stock Units that vested on January 20, 2025. |
| 04/25/2024 | Date the Rule 10b5-1 trading plan was adopted. |
| 04/18/2024 | Date of grant for some of the Restricted Stock Units that vested on January 20, 2025. |
| 08/22/2024 | Date of grant for some of the Restricted Stock Units that vested on January 20, 2025. |
| 01/20/2025 | Date of partial vesting and settlement of Restricted Stock Units. |
| 01/22/2025 | Date of stock sale to cover tax obligations. |
Keywords
Form 4, insider trading, restricted stock units, RSU, Rule 10b5-1, Precision BioSciences, DTIL, J. Jefferson Smith, stock sale, tax obligations
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.